TABLE III.
Day | CD3+CD4+ | CD3+CD8+ | CD8+CD60+ | CD16+56+ | CD19+ | CD23+ | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(%) | mm3 | (%) | mm3 | (%) | mm3 | (%) | mm3 | (%) | mm3 | (%) | mm3 | ||
0 | 28 | 382 | 14 | 194 | 11 | 145 | 8 | 108 | 44 | 598 | 26 | 350 | |
2 weeks | 36 | 368 | 15 | 152 | 9 | 98 | 7 | 75 | 36 | 375 | 18 | 187 | |
6 mo | 38 | 409 | 20 | 221 | 19 | 200 | 9 | 95 | 24 | 263 | 15 | 159 | |
7 mo | 41 | 339 | 23 | 187 | 18 | 149 | 7 | 57 | 17 | 142 | 9 | 73 | |
2.5 yrs | 56 | 393 | 16 | 114 | 13 | 88 | qns | qns | 15 | 108 | 3 | 21 | |
* The distributions of lymphocyte subpopulations in peripheral blood of a child with autoimmune hepatitis was determined, by flow microfluorimetry (Coulter Epics XL/MCL). Data are expressed as mean total cells/mm3 or mean percentage (%) of positive cells. At 12 weeks post diagnosis, Prednisone (15 mg/d) and Azathioprine (Imuran, 50 mg/d) treatment was started.
qns: quantitiy not sufficient; d: daily.